［1］ SHESKE Y. Drug Adjuvant Handbook (药用辅料手册)［M］. Beijing：Chemical Industry Press，2005.
［2］ LI A P, GU L. Research on the adverse of Nimodipine Injection［J］. J Pract Med Tech(实用医技)，2004, 11(5):734-735.
［3］ WU X F, ZHU T L, SHI L. Analysis on the adverse reaction of Xueshuantong injection［J］. Acta Acad Med CPAPF(武警医学院学报), 2008, 17(3):221-222.
［4］ CHEN X Q, JIN Y Y, TANG G. New Materia Medical Pharmacology(新编药物学) ［M］. 16th ed Beijing： People′s Medical Publishing House, 2007：84.
［5］ ZHENG C. Pay close attention to adverse reaction of adjuvant in praeparatum ［J］. J Contin Med Educ(继续医学教育), 20(28):10-14.
［6］ MAO L P, JIN J, MAI W Y. Drug induceol Hemlytic Aonemia induced by Fludara after treatment of ymphoma: a case report［J］. Pract Clin Med(实用临床医学)， 2004, 5(6)：139.
［7］ SOMBERG J C, TIMAR S, BAILIN S J, et al. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone［J］. Am J Cardiol, 2004,3(5):576.
［8］ CHEN H. Cardiopulmonary arrest induced by the Allergic of Vitamin K1 injection ［J］. Adverse Drug React J (药物不良反应杂志)，2006，8（3）：215.
［9］ WILSON K C, REARDON C, THEODORE A C. Propylene glycol toxicity: A severe iatrogenic illness in ICU patients receiving IV benzodiazepines［J］. Chest , 2005,128（3）:1674-1681.
［10］ LI X F, LIN H Q, PAN J C. Prevention and treatment of adverse reactions caused by zedoary turmeric oil glucose injection ［J］. Adverse Drug React J (药物不良反应杂志), 2005, 7（5）:348-350.
［11］ TENG X Y, GUAN Z Z, YAO Z W . A tolerability study of a cremophor albumin bound nanoparticle paclitaxel intravenously administrated in patients with advanced solid tumor ［J］. Chin J Cancer（癌症）, 2004, 23(11s):1431-1436.
［12］ WEI X H，ZHANG J T，WANG W. New development of research on cremophor EL free intravenous injection of paclitaxel［J］. Chin J Pharm（中国医药工业杂志）, 2001, 32(4):188-192.